实用肝脏病杂志 ›› 2015, Vol. 18 ›› Issue (2): 141-144.doi: 10.3969/j.issn.1672-5069.2015.02.009

• 乙型肝炎 • 上一篇    下一篇

谷氨酰转肽酶/HBsAg比值评估慢性乙型肝炎患者肝纤维化的价值探讨*

李旭, 张振华, 蔡群, 谢琴秀, 张亚飞, 江晓平, 李旭, 尹华发   

  1. 230022 合肥市 安徽医科大学第一附属医院感染病科
  • 收稿日期:2014-11-13 出版日期:2015-03-10 发布日期:2016-02-19
  • 通讯作者: 尹华发,E-mail:yhf163.good@163.com
  • 作者简介:李旭,女,32岁,硕士研究生。主要从事病毒性肝炎基础与临床研究。E-mail:31316185@qq.com
  • 基金资助:
    国家自然科学基金资助项目(编号:81273142); 教育部博士点基金资助项目(编号:20093420120005)

Judgement of liver fibrosis by gama-glutamyltransferase to qHBsAg ratio in patients with chronic hepatitis B

Li Xu, Zhang Zhenhua, Cai Qun, et al.   

  1. Department of Infectious Diseases,First Affiliated Hospital,Anhui Medical University,Hefei 230022,China
  • Received:2014-11-13 Online:2015-03-10 Published:2016-02-19
  • Contact: Yin Huafa,E-mail:yhf163.good@163.com

摘要: 目的 评价血清γ-谷氨酰转肽酶(γ-GT)与HBsAg定量比值(GqHBsR)判断慢性乙型肝炎患者肝纤维化程度的价值。方法 在232例进行肝穿刺的慢性乙型肝炎患者,采用美国罗氏公司提供的化学发光法试剂检测HBsAg定量;将≥S2作为显著纤维化组,<S2组作为轻度或无纤维化组,采用受试者工作特征曲线(ROC)评价该比值在不同截点时对于显著性肝纤维化的诊断价值。结果 GqHBsR判断有无显著性肝纤维化时的ROC曲线下面积(AUC)为0.704。当GqHBsR>9.57时,诊断显著肝纤维化的敏感性为49.2%、特异性为88.2%、阳性预测值(PPV)为84.2%、阴性预测值(NPV)为57.7%;当GqHBsR>10时,其特异性和PPV分别为88.2%和83.3%;当GqHBsR>20时,其特异性和PPV均为100%;当GqHBsR<2.4时,其敏感性和阴性预测值分别为98.4%和81.8%;当GqHBsR<2时,其敏感性和阴性预测值均为100%。随着GqHBsR逐渐增大,其特异性和PPV逐渐增大,随着GqHBsR逐渐变小,其敏感性和NPV逐渐增大。在特异性和PPV分别为88.2%和83.3%,敏感性和NPV分别为98.4%和81.8%时,可避免约40%患者进行肝穿刺。基于4因素的肝纤维化指数(FIB-4)、天冬氨酸氨基转移酶与血小板比值(APRI)、γ-GT、HBsAg单独判断有无显著性肝纤维化的AUC分别为0.638、0.631、0.606、0.588,而GqHBsR判断有无显著性肝纤维化的AUC明显优于FIB-4、APRI、γ-GT或HBsAg。结论 非创伤性诊断模型GqHBsR能较好地区分存在显著性肝纤维化,对于慢性乙型肝炎患者的抗病毒治疗或许有一定的指导意义。

关键词: 慢性乙型肝炎, HBsAg, γ, -谷氨酰转肽酶, 肝纤维化

Abstract: Objective To assess the liver fibrosis by serum gama-glutamyltransferase(γ-GT) and HBsAg quantification(qHBsAg) ratio(GqHBsR) in patients with chronic hepatitis B. Methods A total of 232 patients with chronic hepatitis B were enrolled and all had liver biopsied. Serum γ-GT and HBsAg were detected. Liver fibrosis was believed to be significant as ≥S2 and to be mild or without fibrosis as less than S2 existed. Diagnostic efficacy of GqHBsR was assessed at different cut-off values for significant liver fibrosis by using receiver operating characteristic (ROC) curves. Results The area under ROC (AUC) of GqHBsR for significant liver fibrosis was 0.704. When the GqHBsR was greater than 9.570 for significant liver fibrosis,the sensitivity,specificity,positive predictive value(PPV) and negative predictive value(NPV) were 49.2%,88.2%,84.2% and 57.7%;When the GqHBsR was >10 for significant liver fibrosis,the specificity and PPV were 88.2% and 83.3%,respectively;When the GqHBsR was>20 for significant liver fibrosis,specificity and PPV were both 100%;When the GqHBsR was <2.4 for significant liver fibrosis,the sensitive and NPV were 98.4% and 81.8%,respectively;When the GqHBsR was <2 for significant liver fibrosis,the sensitive and NPV were both 100%;The area under ROC(AUC) of fibrosis index based on the 4 factor(FIB-4),aspartate aminotransferase to platelet ratioindex(APRI),γ-GT and HBsAg for significant liver fibrosis were 0.638,0.631,0.606 and 0.588,respectively,all were less efficient as compared to that of GqHBsR. Conclusion GqHBsR yields a higher AUC than aspartate aminotransferase to platelet ratio index,FIB-4,γ-GT or HBsAg. This noninvasive diagnostic models for determination of liver fibrosis might be useful in clinical practice.

Key words: Chronic hepatitisB, Gamma-glutamyltransferase, Hepatitis B surface antigen, Liver fibrosis